Thalidomide for Multiple Myeloma
Completed · Phase 3
Conditions studied: Multiple Myeloma
In brief
The objective of this protocol is to assess therapeutic activity of thalidomide in previously untreated patients with asymptomatic multiple myeloma.
Key facts
- Study ID
- NCT00038233
- Run by
- M.D. Anderson Cancer Center
- People needed
- 27
- Starts
- 1999-05-01
- Expected to finish
- 2005-04-01
- Last updated by the study team
- 2018-10-31
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Texas M. D. Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.